Whitehawk Therapeutics In...

NASDAQ: WHWK · Real-Time Price · USD
1.60
-0.02 (-1.23%)
At close: Aug 15, 2025, 3:59 PM
1.60
0.00%
After-hours: Aug 15, 2025, 04:04 PM EDT

Whitehawk Therapeutics Inc Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
28.67M 62.89M 39.02M 148.99M
Short-Term Investments
18.57M 45.96M 133.54M n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
1.4M 1.87M 2.18M 2.21M
Receivables
5.9M 5.49M 1.86M n/a
Inventory
5.31M 6.43M 1.86M n/a
Other Current Assets
n/a n/a n/a n/a
Total Current Assets
61.29M 124.59M 180.03M 151.27M
Property-Plant & Equipment
7.63M 5.97M 2.03M 614K
Goodwill & Intangibles
n/a n/a n/a 3.81M
Total Long-Term Assets
9.03M 7.84M 4.21M 6.64M
Total Assets
70.32M 132.42M 184.24M 157.91M
Account Payables
2.16M 5.9M 3.52M 6.44M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
64K 5.76M 1.57M n/a
Total Current Liabilities
17.07M 26.39M 18.84M 15.27M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
202K n/a 5.76M 5.76M
Total Long-Term Liabilities
767K 833K 7.02M 6.23M
Total Liabilities
17.84M 27.23M 25.86M 21.5M
Total Debt
833K 1.27M 1.66M 605K
Common Stock
2K 2K 2K 2K
Retained Earnings
-332.65M -268.96M -203.2M -142.69M
Comprehensive Income
16K 27K -115K n/a
Shareholders Equity
52.48M 105.19M 158.38M 136.41M
Total Investments
18.57M 45.96M 133.54M n/a